Hillhouse Capital Advisors »

Odyssey Therapeutics shares owned by Hillhouse Capital Advisors

Quarter-by-quarter ownership of Odyssey Therapeutics shares owned by Hillhouse Capital Advisors from 13F filings

Historical chart of Hillhouse Capital Advisors investment in Odyssey Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Odyssey Therapeutics held by Hillhouse Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Odyssey Therapeutics by Hillhouse Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $16M 832k 18.71

More positions owned by Hillhouse Capital Advisors

Legend Biotech Corp Sponsored Ads (LEGN)
Futu Hldgs Spon Ads Cl A (FUTU)
Arrivent Biopharma (AVBP)
Marvell Technology (MRVL)
Vipshop Hldgs Sponsored Ads A (VIPS)
Pdd Holdings Sponsored Ads (PDD)
Ke Hldgs Sponsored Ads (BEKE)
Cytek Biosciences (CTKB)
Alamar Biosciences Common Stock
Alibaba Group Hldg Sponsored Ads (BABA)
Odyssey Therapeutics Common Stock
Yatsen Hldg Sponsored Ads (YSG)
Novabridge Biosciences Sponsored Ads (NBP)
Contineum Therapeutics Cl A (CTNM)
Maze Therapeatics (MAZE)

View all positions for Hillhouse Capital Advisors

Top funds holding Odyssey Therapeutics

Sr One Capital Management
Lightspeed Management Company
Sanofi
Hillhouse Capital Advisors
Affinity Asset Advisors
Vanguard Capital Management
Marshall Wace
Redmile Group
Citadel Advisors
Standard Life Aberdeen
Goldman Sachs Group
Vanguard Fiduciary Trust
TD Asset Management
Jpmorgan Chase & Co
Burkehill Global Management

View all funds holding Odyssey Therapeutics